Express News | NYSE Order Imbalance 175144.0 Shares on Sell Side
Stocks With the Highest and Lowest Liquidity - Goldman Sachs
Express News | NYSE Order Imbalance 84104.0 Shares on Sell Side
Truist Financial Maintains Agilon Health(AGL.US) With Hold Rating
Truist Financial analyst Jailendra Singh maintains $Agilon Health(AGL.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 29.9% and a total average return of -15.5% o
Express News | NYSE Order Imbalance 62722.0 Shares on Buy Side
JMP Securities Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $8
JMP Securities analyst Constantine Davides maintains $Agilon Health(AGL.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 26.4%
Agilon Health Shares Are Trading Higher After the Company Appointed Schwaneke as CFO.
Agilon Health Shares Are Trading Higher After the Company Appointed Schwaneke as CFO.
Agilon Health Appoints Jeff Schwaneke As New CFO, Effective July 1, 2024
agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and mana
Express News | Agilon Health Inc: Schwaneke takes over Timothy Bensley's position.
Express News | Agilon Health Inc: Schwaneke Succeeds Timothy Bensley
Agilon Health: Timothy Bensley Announced His Retirement From Agilon in Early 2024 >AGL
Agilon Health: Timothy Bensley Announced His Retirement From Agilon in Early 2024 >AGL
Agilon Health Names Jeff Schwaneke New Chief Financial Officer >AGL
Agilon Health Names Jeff Schwaneke New Chief Financial Officer >AGL
Express News | NYSE Order Imbalance 103033.0 Shares on Buy Side
Express News | NYSE Order Imbalance 131164.0 Shares on Buy Side
Managed Care Poised for Long-term Growth Despite Recent Headwinds: Baird
Agilon Health Initiated at Neutral by Baird
Agilon Health Initiated at Neutral by Baird
Agilon Health (AGL.US) was covered for the first time by Baird, with a neutral rating, with a target price of $6.00.
Agilon Health (AGL.US) was covered for the first time by Baird, with a neutral rating, with a target price of $6.00.
Baird Initiates Coverage On Agilon Health With Neutral Rating, Announces Price Target of $6
Baird analyst Michael Halloran initiates coverage on Agilon Health with a Neutral rating and announces Price Target of $6.
Agilon Health to Participate at 44th Annual William Blair Growth Stock Conference
agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 44th Annual William Blair Growth Stock Conference
Express News | NYSE Order Imbalance 77983.0 Shares on Sell Side
No Data